Olectra Greentech Ltd has been in focus on Wednesday. On January 15, 2025, Olectra Greentech share price (NSE: OLECTRA) opened at ₹1,409.00, down from its previous close of ₹1,435.95. At 11:20 AM, the share price of Olectra Greentech was trading at ₹1,389.10, down by 3.26% on the NSE. Notably, the stock price touched its 52-week low recently on January 13, 2025, at ₹1,240.00.

Q2 FY 2025 Financial Highlights

For Q2 FY25, the company reported a total income of ₹52,618.84 lakh, a significant increase compared to ₹31,028.36 lakh in Q2 FY24. For the first half of FY25 (H1 FY25), total income reached ₹84,318.48 lakh, up from ₹52,750.56 lakh in H1 FY24.

Net profit after tax for Q2 FY25 stood at ₹4,765.29 lakh, a substantial rise from ₹1,857.92 lakh in Q2 FY24. In H1 FY25, net profit amounted to ₹7,190.61 lakh, a notable increase from ₹3,665.16 lakh in H1 FY24.

About Olectra Greentech Ltd

Olectra Greentech Limited was founded in 2000. The company specialises in the production of composite polymer insulators and electric buses. Olectra Greentech Limited is headquartered in Hyderabad.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Network18 Media & Investments Limited released its financial results for the quarter ended December 31, 2024.

Q3 FY 2025 Financial Highlights

The News Business recorded an operating revenue of ₹476 crore in Q3 FY25, reflecting a 2% year-on-year (YoY) growth compared to ₹469 crore in Q3 FY24. For the nine months ended December 31, 2024 (9M FY25), operating revenue stood at ₹1,374 crore, marking a 7% YoY increase from ₹1,283 crore in 9M FY24.

During Q3 FY25, operating expenses grew by 4% YoY, leading to lower EBITDA for the quarter. However, for 9M FY25, EBITDA improved significantly, driven by a 7% revenue growth compared to a 4% rise in costs.

Business Developments

Moneycontrol Pro achieved a significant milestone, surpassing 1 million paid subscribers, further cementing its status as India’s leading subscription-based financial intelligence platform. Additionally, Moneycontrol’s fintech business scaled up rapidly as a lending service provider.

The company’s TV News network share improved by 110 basis points (bps) quarter-on-quarter (QoQ), maintaining its leadership in key markets. Notably, News18 Lokmat emerged as the #1 Marathi news channel, a remarkable turnaround over the past year.

Viacom18 completed its merger with Star India on November 14, 2024, creating one of India’s largest broadcasting and digital streaming companies. Network18 holds a 6.3% effective economic interest in the joint venture through its stake in Viacom18.

Commenting on the performance, the Chairman of Network18, Mr Adil Zainulbhai, said, “The restructuring of the business is now complete, simplifying the corporate structure for all our stakeholders. We are pleased with the progress made on the operating front, especially the manner in which our television network is growing. Having established leadership positions in national markets, we are now focused on select regional markets for driving the next phase of growth. Our Digital business is also gaining momentum, and we are harnessing the combined strength of our platforms to deliver a superlative and seamless experience to our consumers.”

On January 15, 2025, Network18 Media & Investments share price (NSE: NETWORK18) opened at ₹61.31, touching the day’s low at ₹60.60, as of 9:40 AM on the NSE.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

IDBI Bank Ltd has been in focus on Wednesday. On January 15, 2025, IDBI share price opened at ₹74.90, down from its previous close of ₹77.90. At 10:56 AM, the share price of IDBI was trading at ₹72.95, down by 6.35% on the NSE. Notably, the stock price touched its 52-week low recently on January 13, 2025, at ₹65.89.

Earlier this week in January 2025, IDBI Bank announced that its Board of Directors will meet on Monday, January 20, 2025, to review and approve the unaudited financial results for the quarter and nine months ended December 31, 2024, subject to a limited review by the statutory auditors.

Financial Highlights for Q2 FY 2025

For Q2 FY 2025, the bank’s net profit surged to ₹1,836 crore, reflecting a 39% year-on-year (YoY) growth and a 7% quarter-on-quarter (QoQ) increase. Net Interest Income (NII) stood at ₹3,875 crore, marking a 26% YoY growth, with a Net Interest Margin (NIM) of 4.87%, up 54 basis points YoY.

The Gross Non-Performing Assets (NPA) ratio improved to 3.68%, showing a reduction of 122 basis points YoY. Total deposits increased to ₹2,77,602 crore, up 11% YoY, while Net Advances grew by 19% YoY to ₹2,00,944 crore, reflecting the company’s healthy growth trajectory.

About IDBI Bank Ltd

IDBI Bank is involved in the business of monetary intermediation of commercial banks, saving banks, postal savings banks and discount houses.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

On January 15, 2025, as of 12:04 PM, the BSE Sensex was up by 0.40% at 76,803.31, while the Nifty50 was up by 0.3% at 23,242.30. Among sectors, the Nifty MidSmall Healthcare dropped 1.32%.

As of January 15, 2025, 12:05 PM, the mid-day top gainers and losers are:

Mid-Day Top Gainers 

• NTPC

NTPC share price surged 4.06% after opening at ₹312.55. The stock hit the day’s high of ₹324.30.

• Power Grid Corporation of India

Power Grid share price rose 4.08% after opening at ₹295.00. The stock touched its day’s high at ₹302.50.

• Trent

Trent share price gained 3.88% after opening at ₹6,200.00. The stock touched the day’s high at ₹6,411.10.

• Maruti Suzuki India

Maruti Suzuki share price surged 2.51% after opening at ₹11,890.55. It hit a day’s high of ₹12,192.40.

• Coal India

Coal India share price rose by 2.38%. The stock opened at ₹371.90 and hit a day’s high of ₹381.45.

Mid-Day Top Losers

• Mahindra & Mahindra (M&M)

M&M share price dropped 2.70%. The stock opened at ₹3,057.10 and touched its day’s low at ₹2,957.00.

• HDFC Life Insurance Company

HDFC Life share price fell 2.18%. The share price opened at ₹604.50 and touched its day’s low at ₹584.30. The company has scheduled January 15, 2025, to announce its Q3 FY 2025 financial results.

• Shriram Finance

Shriram Finance share price dropped 2.22%. The share price opened at ₹545.00 and touched its day’s low at ₹529.10.

• Bajaj Finance

Bajaj Finance share price slipped 2.43%. The share price opened at ₹7,340.50 and touched its day’s low at ₹7,105.20.

• Bajaj Finserv

Bajaj Finserv share price slipped 2.39%. The share price opened at ₹1,721.10 and touched its day’s low at ₹1,650.00.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Indian Overseas Bank (IOB) has been in focus on Wednesday. On January 15, 2025, IOB share price opened at ₹51.80, down from its previous close of ₹53.77. At 10:34 AM, the share price of IOB was trading at ₹49.90, down by 7.20% on the NSE.

This focus was followed by news reports stating that ahead of the upcoming Union Budget for 2025-2026, the Indian government may reduce its stake in five major Public Sector Undertaking (PSU) banks.

Q2 FY 2025 Financial Highlights

For the quarter ending September 30, 2024 (Q2 FY25), the company reported strong financial performance, with total business showing a significant year-on-year (YoY) growth of 12.2%. Total business reached ₹5,40,801 crore, up from ₹4,82,006 crore in the previous year. This growth was driven by a 13.75% increase in total deposits, which stood at ₹3,10,652 crore, as well as a 10.16% rise in gross advances, which amounted to ₹2,30,149 crore. These positive metrics highlight the company’s strong position in the market and its continued expansion.

The bank also reported substantial growth in profitability, with operating profit increasing by 26.89% YoY to ₹2,128 crore, up from ₹1,677 crore in the same period last year. Net profit saw a notable rise of 24.32% YoY, reaching ₹777 crore.

About Indian Overseas Bank

Indian Overseas Bank (IOB), founded on February 10, 1937, by Shri M.Ct.M. Chidambaram Chettyar, has a deep-rooted legacy and a robust presence in the banking sector. Nationalised in 1969, IOB now operates 3,277 branches, 3,501 ATMs, and employs 8,194 business correspondents across India. The bank also has an international presence in four countries: Singapore, Hong Kong, Thailand, and Sri Lanka, catering to over 41 million active customers.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

HDFC Life Insurance Company Limited is gaining attention on Wednesday ahead of the Q3 FY 2025 financial results announcement.

On January 15, 2025, HDFC Life share price (NSE: HDFCLIFE) opened at ₹604.50, down from its previous close of ₹600.45. At 10:16 AM, the share price of HDFC Life was trading at ₹591.45, down by 1.50% on the NSE. As of the same time, the stock touched its day’s low so far at ₹589.80.

Board Meeting Announcement

In December 2024, the company announced that its Board of Directors would convene on Wednesday, January 15, 2025, to review the unaudited financial results for the quarter and the nine months ending December 31, 2024.

Financial Performance in H1 FY 2025

The company reported an AUM of ₹3.25 lakh crore as of September 30, 2024, reflecting a 23% increase in H1 FY25. The Profit After Tax (PAT) for H1 FY25 reached ₹911 crore, marking a 15% year-on-year growth. The private sector market share in individual WRP grew by 60 bps to 16.3%, and the overall market share reached a record high of 11%.

About HDFC Life Insurance Company Limited

HDFC Life Insurance Company is involved in carrying out the business of life insurance. The company provides a wide range of individual and group insurance solutions. The company’s portfolio contains several insurance and investment products such as pension, savings, protection, etc.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

HDFC Asset Management Company Limited (HDFC AMC) has announced its financial results for the quarter ended December 31, 2024.

Post the announcement, on January 15, 2025, HDFC AMC share price opened at ₹3,901.85, up from its previous close of ₹3,865.05. At 10:07 AM, the share price of HDFC AMC was trading at ₹4,056.70, up by 4.96% on the NSE.

Q3 FY 2025 Performance

The company reported financial growth for Q3 FY25, with revenue from operations reaching ₹9,343 million, reflecting a 39% increase compared to Q3 FY24. Operating profit stood at ₹7,472 million, marking a 51% growth year-on-year.

The company continues to strengthen its position in the mutual fund industry, maintaining a market share of 11.5% in Quarterly Average Assets Under Management (QAAUM) for Q3 FY25.

HDFC AMC is also among the largest actively managed equity mutual fund managers, with a QAAUM market share of 12.8% for the same period.

Furthermore, the company stated that it remains a preferred choice for individual investors, holding a 13.2% market share of the individual monthly average AUM for December 2024. Notably, 70% of the company’s total monthly average AUM comes from individual investors, surpassing the industry average of 61%.

HDFC AMC’s QAAUM for the quarter ended December 31, 2024, stood at ₹7,874 billion, up significantly from ₹5,515 billion in Q3 FY24. The company also reported a total of 22.1 million live accounts as of December 31, 2024. Additionally, unique customers, as identified by PAN or PEKRN, totalled 12.6 million, achieving a penetration of 24% within the industry, which has a total of 52.6 million unique customers.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Shoppers Stop Ltd has declared its results for the quarter ended December 31, 2024. Post the announcement, on January 15, 2025, Shoppers Stop share price (NSE: SHOPERSTOP) opened at ₹667.95, up from its previous close of ₹620.20. At 9:54 AM, the share price of Shoppers Stop was trading at ₹659.40, up by 6.32% on the NSE.

Q3 FY 2025 Financial Highlights

For Q3 FY25, the company reported a GAAP sales revenue of ₹1,311 crore, reflecting a 9% year-on-year (YoY) growth compared to ₹1,207 crore in Q3 FY24. On a Non-GAAP basis, sales revenue stood at ₹1,585 crore, up by 7% YoY from ₹1,483 crore in the same quarter last year, showcasing consistent growth across reporting standards.

Profit After Tax (PAT) for the quarter grew significantly. On a GAAP basis, PAT increased by 37% YoY to ₹49 crore, compared to ₹35 crore in Q3 FY24. Similarly, on a Non-GAAP basis, PAT stood at ₹45 crore, marking an 11% YoY growth from ₹40 crore in the corresponding quarter of the previous year. These results underscore the company’s robust performance and focus on profitability.

Nine Months FY 2025 Financial Highlights

For the nine months ended FY25, the company recorded GAAP sales revenue of ₹3,413 crore, representing a 6% year-on-year (YoY) growth compared to ₹3,213 crore in the same period of FY24. On a Non-GAAP basis, sales revenue was ₹4,143 crore, up by 4% YoY from ₹3,996 crore, indicating steady revenue growth across both reporting methods.

However, Profit After Tax (PAT) for the nine-month period declined significantly. On a GAAP basis, PAT dropped by 93% YoY to ₹4 crore, compared to ₹52 crore in FY24. On a Non-GAAP basis, PAT fell by 71% YoY to ₹15 crore from ₹50 crore in the prior year, reflecting challenges in profitability despite revenue growth.

Commenting on the Q3FY25 results, the MD and CEO of Shoppers Stop Ltd, Mr Kavindra Mishra, said, “We have improved every KPI’s during the quarter. Our strategic focus is to make Private Brands profitable. I am extremely pleased to say that Private Brands generated healthy margin growth, driven by lower markdown and obsolescence. The Beauty category continues to grow, Sales grew +3%, led by a Fragrance +14%. Our flagship store at Inorbit Malad, Mumbai, has been fully renovated and is now operational, featuring premium product offerings and enhanced customer experiences.”

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Time Medical International Ventures (India) Private Limited, a wholly owned subsidiary of Fischer Medical Ventures Limited, has made a groundbreaking achievement by becoming the first indigenous MRI manufacturer in India to receive the official License to Manufacture for Sale or Distribution of Magnetic Resonance Diagnostic Devices (MRDD) from the Central Drugs Standard Control Organization (CDSCO).

Details of the License 

This milestone is a significant step forward for the Make in India initiative and underscores the company’s commitment to producing high-quality, locally manufactured medical devices that meet stringent international standards.

With this new license, Time Medical is poised to manufacture and distribute advanced MRI systems across India. The company’s product lineup includes the EMMA, MICA, and QUIN MRI systems, all of which are 1.5T MRI scanners that offer exceptional imaging resolution and precision for a wide range of clinical applications. Additionally, the PICA model, a 0.35T MRI scanner, is tailored for specific diagnostic needs. These systems are FDA and CE-approved, ensuring that they meet global safety, quality, and regulatory standards.

The company stated that this achievement not only supports the growing demand for reliable and advanced medical imaging solutions in India but also aligns with Fischer Medical Ventures’ dedication to enhancing diagnostic capabilities and improving healthcare delivery across the country.

Commenting on this development, the Management Team of Fischer Medical Ventures, said, “We are thrilled to be the first Make in India company to receive the CDSCO license for the manufacturing and distribution of MRI systems. This achievement demonstrates the strength and potential of India’s medical device manufacturing sector. With our EMMA, PICA, MICA, and QUIN MRI systems, we are committed to providing hospitals and diagnostic centres with cutting-edge, affordable diagnostic imaging solutions.”

On January 14, 2025, Fischer Medical Ventures share price opened at ₹703.20, touching the day’s high at ₹730.00, as of 1:01 PM on the NSE.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.